✦ LIBER ✦

TP53INP1 as new therapeutic target in castration-resistant prostate cancer

✍ Scribed by Sophie Giusiano; Virginie Baylot; Claudia Andrieu; Ladan Fazli; Martin Gleave; Juan Lucio Iovanna; Colette Taranger-Charpin; Stéphane Garcia; Palma Rocchi

Book ID: 112179606
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 481 KB
Volume: 72
Category: Article
ISSN: 0270-4137
DOI: 10.1002/pros.22477

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endothelin Receptors as Therapeutic Targ

Endothelin Receptors as Therapeutic Targets in Castration-Resistant Prostate Cancer

✍ Joel B. Nelson 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 399 KB

Cholesterol as a Potential Target for Ca

Cholesterol as a Potential Target for Castration-Resistant Prostate Cancer

✍ Alexis L. Twiddy; Carlos G. Leon; Kishor M. Wasan 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 689 KB

Enzalutamide (formerly MDV3100) as a new

Enzalutamide (formerly MDV3100) as a new therapeutic option for men with metastatic castration-resistant prostate cancer

✍ Aragon-Ching, Jeanny B 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

Emerging therapeutic approaches in the m

Emerging therapeutic approaches in the management of metastatic castration-resistant prostate cancer

✍ Antonarakis, E S; Armstrong, A J 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 530 KB

Hsp90 as a therapeutic target in prostat

Hsp90 as a therapeutic target in prostate cancer

✍ David B Solit; Howard I Scher; Neal Rosen 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Endothelin-1 as a Target for Therapeutic

Endothelin-1 as a Target for Therapeutic Intervention in Prostate Cancer

✍ E. Scott Kopetz; Joel B. Nelson; Michael A. Carducci 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 316 KB